Dilip Joseph

In a report rolled out Monday, Wedbush analysts David M. Nierengarten, Dilip Joseph and Robert Driscoll reiterated an Outperform rating on shares of Anacor Pharmaceuticals Inc (NASDAQ: ANAC), while boosting their price target from $85 to $190. Shares of Anacor were up more than 55 percent on...

In a report published Monday, Wedbush analysts David M. Nierengarten, Ph.D., and Dilip Joseph previewed fourth quarter earnings for Raptor Pharmaceutical Corp. (NASDAQ: RPTP), “lowering sales estimates with US market saturation and slow EU launch.” The specialists reiterated an...